Diabetes complications

被引:69
作者
Bloomgarden, ZT [1 ]
机构
[1] Mt Sinai Sch Med, Ctr Diabet, New York, NY USA
关键词
D O I
10.2337/diacare.27.6.1506
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:1506 / 1514
页数:9
相关论文
共 58 条
[1]
The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort [J].
Abbott, CA ;
Carrington, AL ;
Ashe, H ;
Bath, S ;
Every, LC ;
Griffiths, J ;
Hann, AW ;
Hussein, A ;
Jackson, N ;
Johnson, KE ;
Ryder, CH ;
Torkington, R ;
Van Ross, ERE ;
Whalley, AM ;
Widdows, P ;
Williamson, S ;
Boulton, AJM .
DIABETIC MEDICINE, 2002, 19 (05) :377-384
[2]
Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot [J].
Abouaesha, F ;
van Schie, CHM ;
Griffths, GD ;
Young, RJ ;
Boulton, AJM .
DIABETES CARE, 2001, 24 (07) :1270-1274
[3]
Decreased left ventricular longitudinal contraction in normotensive and normoalbum inuric patients with Type II diabetes mellitus:: a Doppler tissue tracking and strain rate echocardiography study [J].
Andersen, NH ;
Poulsen, SH ;
Eiskjær, H ;
Poulsen, PL ;
Mogensen, CE .
CLINICAL SCIENCE, 2003, 105 (01) :59-66
[4]
Off-loading the diabetic foot wound - A randomized clinical trial [J].
Armstrong, DG ;
van Schie, CHM ;
Nguyen, HC ;
Boulton, AJM ;
Lavery, LA ;
Harkless, LB .
DIABETES CARE, 2001, 24 (06) :1019-1022
[5]
Activity patterns of patients with diabetic foot ulceration - Patients with active ulceration may not adhere to a standard pressure off-loading regimen [J].
Armstrong, DG ;
Lavery, LA ;
Kimbriel, HR ;
Nixon, BP ;
Boulton, AJM .
DIABETES CARE, 2003, 26 (09) :2595-2597
[6]
Androgen receptor-mediated inhibition of cutaneous wound healing [J].
Ashcroft, GS ;
Mills, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (05) :615-624
[7]
Add-on anti-TGF-β antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat [J].
Benigni, A ;
Zoja, C ;
Corna, D ;
Zatelli, C ;
Conti, S ;
Campana, M ;
Gagliardini, E ;
Rottoli, D ;
Zanchi, C ;
Abbate, M ;
Ledbetter, S ;
Remuzzi, G .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07) :1816-1824
[8]
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy [J].
Berl, T ;
Hunsicker, LG ;
Lewis, JB ;
Pfeffer, MA ;
Porush, JG ;
Rouleau, JL ;
Drury, PL ;
Esmatjes, E ;
Hricik, D ;
Parikh, CR ;
Raz, I ;
Vanhille, P ;
Wiegmann, TB ;
Wolfe, BM ;
Locatelli, F ;
Goldhaber, SZ ;
Lewis, EJ .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (07) :542-549
[9]
Blakytny Robert, 2000, Journal of Pathology, V190, P589, DOI 10.1002/(SICI)1096-9896(200004)190:5<589::AID-PATH553>3.0.CO
[10]
2-T